Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 7 | 2025 | 398 | 2.210 |
Why?
|
| Neoplastic Syndromes, Hereditary | 4 | 2025 | 77 | 1.720 |
Why?
|
| von Hippel-Lindau Disease | 3 | 2025 | 16 | 1.650 |
Why?
|
| Paraganglioma | 2 | 2025 | 22 | 1.460 |
Why?
|
| Pheochromocytoma | 2 | 2025 | 37 | 1.450 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2025 | 77 | 1.380 |
Why?
|
| Multiple Endocrine Neoplasia | 2 | 2025 | 10 | 1.090 |
Why?
|
| Jaw Neoplasms | 2 | 2025 | 6 | 1.080 |
Why?
|
| Hyperparathyroidism | 2 | 2025 | 26 | 1.070 |
Why?
|
| Carney Complex | 1 | 2025 | 2 | 0.950 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2025 | 3265 | 0.950 |
Why?
|
| Medulloblastoma | 6 | 2019 | 379 | 0.810 |
Why?
|
| Cerebellar Neoplasms | 6 | 2019 | 315 | 0.750 |
Why?
|
| Wilms Tumor | 4 | 2025 | 116 | 0.710 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 30 | 0.540 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2017 | 50 | 0.540 |
Why?
|
| Beckwith-Wiedemann Syndrome | 2 | 2024 | 16 | 0.430 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 727 | 0.400 |
Why?
|
| Germ-Line Mutation | 5 | 2025 | 352 | 0.400 |
Why?
|
| Child | 22 | 2025 | 25228 | 0.390 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2012 | 25 | 0.390 |
Why?
|
| Radiotherapy | 1 | 2012 | 120 | 0.360 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 5 | 0.360 |
Why?
|
| Hearing Loss | 2 | 2017 | 199 | 0.360 |
Why?
|
| Connexins | 1 | 2011 | 55 | 0.350 |
Why?
|
| Hepatoblastoma | 2 | 2024 | 186 | 0.300 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2025 | 34 | 0.280 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 264 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 252 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2019 | 1032 | 0.260 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 12 | 0.240 |
Why?
|
| Humans | 31 | 2025 | 127099 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 744 | 0.230 |
Why?
|
| Kidney Neoplasms | 3 | 2025 | 438 | 0.230 |
Why?
|
| Ribonuclease III | 2 | 2017 | 101 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2017 | 160 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2747 | 0.220 |
Why?
|
| Retinoblastoma | 1 | 2025 | 80 | 0.220 |
Why?
|
| Retinal Neoplasms | 1 | 2025 | 69 | 0.210 |
Why?
|
| Mutation | 5 | 2020 | 5947 | 0.210 |
Why?
|
| Adolescent | 12 | 2025 | 20082 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 4 | 2025 | 1273 | 0.190 |
Why?
|
| Gadolinium | 1 | 2021 | 110 | 0.170 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 19 | 0.160 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 28 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 86 | 0.150 |
Why?
|
| Cisplatin | 2 | 2017 | 269 | 0.150 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2018 | 8 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 234 | 0.150 |
Why?
|
| Vascular Malformations | 1 | 2020 | 107 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 49 | 0.140 |
Why?
|
| Genotype | 4 | 2022 | 2598 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 1235 | 0.140 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 64 | 0.140 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 3 | 0.140 |
Why?
|
| Leiomyomatosis | 1 | 2017 | 7 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 38 | 0.130 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2017 | 20 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 53 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2020 | 14423 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 54 | 0.130 |
Why?
|
| Fibroma | 1 | 2017 | 29 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 241 | 0.130 |
Why?
|
| Sacroiliac Joint | 1 | 2016 | 4 | 0.130 |
Why?
|
| Neurofibrosarcoma | 1 | 2016 | 5 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 27 | 0.130 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2016 | 19 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 2016 | 18 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 480 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2016 | 27 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 1350 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 104 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2017 | 177 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 265 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 142 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 283 | 0.120 |
Why?
|
| Infant | 8 | 2023 | 12784 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 22 | 0.120 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 252 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 395 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 170 | 0.110 |
Why?
|
| Microcephaly | 1 | 2017 | 344 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 477 | 0.110 |
Why?
|
| Pinealoma | 1 | 2014 | 19 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 21 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 588 | 0.100 |
Why?
|
| Female | 13 | 2020 | 68483 | 0.100 |
Why?
|
| Young Adult | 5 | 2020 | 9694 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 623 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 656 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 979 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2012 | 45 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1867 | 0.090 |
Why?
|
| Male | 12 | 2020 | 62658 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1598 | 0.090 |
Why?
|
| Connexin 26 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1098 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 963 | 0.090 |
Why?
|
| Risk Factors | 4 | 2017 | 10610 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 58 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 900 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 29 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2011 | 359 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 39 | 0.080 |
Why?
|
| Thiolester Hydrolases | 1 | 2010 | 6 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 425 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 56 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3714 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 880 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1054 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 155 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 150 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1508 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1561 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2344 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2856 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2010 | 438 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 637 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2025 | 1056 | 0.060 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2025 | 10 | 0.060 |
Why?
|
| Phenotype | 3 | 2020 | 4306 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 781 | 0.060 |
Why?
|
| Australia | 1 | 2024 | 172 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 808 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 30435 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2003 | 148 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 162 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 122 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 4799 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 45 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5148 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 197 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 247 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 4972 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 461 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17065 | 0.030 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2017 | 4 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 27801 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 355 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 110 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 85 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1758 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 249 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 355 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 802 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 361 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 511 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 690 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3259 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2017 | 228 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8350 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 332 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 197 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1369 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 403 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 277 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1399 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 891 | 0.030 |
Why?
|
| Family Health | 1 | 2014 | 248 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1206 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2896 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1891 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Yin-Yang | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2397 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3034 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 168 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 684 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3322 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 348 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 406 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3563 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 649 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1921 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1231 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2564 | 0.010 |
Why?
|
| Virus Inactivation | 1 | 2003 | 9 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 23 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2003 | 48 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 111 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 79 | 0.010 |
Why?
|
| Bronchi | 1 | 2003 | 103 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11386 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 841 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 593 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2003 | 357 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 872 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 33157 | 0.010 |
Why?
|